Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Cancer Chemotherapy and Pharmacology|June 3, 2015
Pharmacokinetic drug-drug interaction assessment of peptibody trebananib in combination with chemotherapiesBenjamin Wu, Rebeca Melara, Erik Rasmussen, et al.Bioanalysis|December 23, 2025
A systematic approach to improve the initial success rates of bioanalytical assay transfers to contract research organizationsMing Li, Jay Ma, Mark Ma, et al.Journal of Medicinal Chemistry|April 17, 2008
Design and synthesis of conformationally constrained glucagon-like peptide-1 derivatives with increased plasma stability and prolonged in vivo activityLes P Miranda, Katherine A Winters, Colin V Gegg, et al.Protein Science : a Publication of the Protein Society|March 18, 2025
Visualizing and analyzing 3D biomolecular structures using Mol* at RCSB.org: Influenza A H5N1 virus proteome case studySebastian Bittrich, Alexander S Rose, David Sehnal, et al.Cancer Biology & Therapy|February 13, 2010
Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor typesPaula J Kaplan-Lefko, Jonathan D Graves, Stephen J Zoog, et al.Bioanalysis|October 11, 2012
2012 white paper on recent issues in bioanalysis and alignment of multiple guidelinesBinodh DeSilva, Fabio Garofolo, Mario Rocci, et al.Bioanalysis|December 16, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 1--small molecules by LCMS)Eric Fluhler, Roger Hayes, Fabio Garofolo, et al.Bioanalysis|December 24, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 3 - LBA and immunogenicity)Lauren Stevenson, Lakshmi Amaravadi, Heather Myler, et al.Bioanalysis|December 23, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 2 - hybrid LBA/LCMS, ELN & regulatory agencies' input)Dawn Dufield, Hendrik Neubert, Fabio Garofolo, et al.Bioanalysis|December 5, 2015
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3--LBA, biomarkers and immunogenicity)Lakshmi Amaravadi, An Song, Heather Myler, et al.Pageof 6